AU2003203884A1 - Pharmaceutical uses of optically pure (-) -bupropion - Google Patents

Pharmaceutical uses of optically pure (-) -bupropion

Info

Publication number
AU2003203884A1
AU2003203884A1 AU2003203884A AU2003203884A AU2003203884A1 AU 2003203884 A1 AU2003203884 A1 AU 2003203884A1 AU 2003203884 A AU2003203884 A AU 2003203884A AU 2003203884 A AU2003203884 A AU 2003203884A AU 2003203884 A1 AU2003203884 A1 AU 2003203884A1
Authority
AU
Australia
Prior art keywords
bupropion
optically pure
pharmaceutical uses
pharmaceutical
optically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003203884A
Inventor
James W Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sunovion Pharmaceuticals Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of AU2003203884A1 publication Critical patent/AU2003203884A1/en
Abandoned legal-status Critical Current

Links

AU2003203884A 1998-01-29 2003-04-24 Pharmaceutical uses of optically pure (-) -bupropion Abandoned AU2003203884A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60072931 1998-01-29

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU24835/99A Division AU2483599A (en) 1998-01-29 1999-01-28 Pharmaceutical uses of optically pure (-)-bupropion

Publications (1)

Publication Number Publication Date
AU2003203884A1 true AU2003203884A1 (en) 2003-06-12

Family

ID=

Similar Documents

Publication Publication Date Title
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
EP1001813B8 (en) Pharmaceutical formulations containing voriconazole
AU1936401A (en) Photodefinition of optical devices
AU1408199A (en) Patient support surfaces
AU6740298A (en) Pharmaceutical composition
AUPN411195A0 (en) Medicinal composition
AU8636398A (en) Hand cleanser
AU8107998A (en) Pharmaceutical compositions
AU4779399A (en) Pharmaceutical levothyroxine preparation
AU8591898A (en) Pharmaceutical compounds
AU5570899A (en) Purified human papillomavirus
AU9343098A (en) Pharmaceutical composition
AU8698898A (en) High purity alkoxytrimethylsilane fluids
AU1044799A (en) Pharmaceutical composition containing zafirlukast
AU2241699A (en) Expression of proteolytically-sensitive peptides
AUPP332898A0 (en) Pharmaceutical composition
AU6480299A (en) Pharmaceutical compounds
AU3490499A (en) Vision architecture to describe features of persons
AU1688099A (en) Pharmaceutical preparation
AU3615697A (en) External fixator
AU7711800A (en) Novel uses of 2-bromopalmitate
AU8102498A (en) Preparation of diaryl-benzopyrans
AU6034298A (en) Two human homologues of galectin-5
AU2965199A (en) Medicine mini-chest
AU2003203884A1 (en) Pharmaceutical uses of optically pure (-) -bupropion